Oscar Health, Inc. (OSCR)
NYSE: OSCR · Real-Time Price · USD
15.65
+1.50 (10.60%)
At close: Jun 5, 2025, 4:00 PM
15.67
+0.01 (0.10%)
After-hours: Jun 5, 2025, 7:59 PM EDT

Oscar Health Stock Forecast

Stock Price Forecast

According to 5 professional analysts, the 12-month price target for Oscar Health stock ranges from a low of $12 to a high of $28. The average analyst price target of $18.5 forecasts a 18.21% increase in the stock price over the next year.

Price Target: $18.50 (+18.21%)
Analyst Consensus: Hold
Target Low Average Median High
Price $12 $18.5 $16 $28
Change -23.32% +18.21% +2.24% +78.91%
* Price targets were last updated on Mar 13, 2025.

Analyst Ratings

The average analyst rating for Oscar Health stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating Jan '25Feb '25Mar '25Apr '25May '25Jun '25
Strong Buy 000000
Buy 443331
Hold 223332
Sell 222222
Strong Sell 000000
Total 888885

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Wells Fargo
Wells Fargo
Hold
Downgrades
$20$16
Hold Downgrades $20$16 +2.24% Mar 13, 2025
Jefferies
Jefferies
Sell
Initiates
$12
Sell Initiates $12 -23.32% Dec 10, 2024
B of A Securities
B of A Securities
Sell
Downgrades
$21$14
Sell Downgrades $21$14 -13.74% Nov 6, 2024
UBS
UBS
Hold
Initiates
$23
Hold Initiates $23 +46.96% Oct 7, 2024
Piper Sandler
Piper Sandler
Buy
Reiterates
$28
Buy Reiterates $28 +78.91% Sep 10, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
11.55B
from 9.18B
Increased by 25.86%
Revenue Next Year
11.59B
from 11.55B
Increased by 0.34%
EPS This Year
0.70
from 0.10
Increased by 597.68%
EPS Next Year
0.92
from 0.70
Increased by 31.21%
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
390.99M1.89B3.96B5.86B9.18B11.55B11.59B13.52B
Revenue Growth
-17.79%384.43%109.27%47.92%56.54%25.86%0.34%16.65%
EPS
-14.16-3.20-2.85-1.220.100.700.922.01
EPS Growth
-----597.68%31.21%119.13%
Forward PE
-----22.4317.107.80
No. Analysts
-----10108
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202520262027
High 12.5B 13.3B 14.9B
Avg 11.6B 11.6B 13.5B
Low 10.8B 10.4B 11.4B

Revenue Growth

Revenue Growth 202520262027
High
36.0%
15.3%
28.9%
Avg
25.9%
0.3%
16.7%
Low
18.0%
-9.9%
-1.8%

EPS Forecast

EPS 202520262027
High 0.92 1.18 2.36
Avg 0.70 0.92 2.01
Low 0.59 0.54 1.72

EPS Growth

EPS Growth 202520262027
High
824.0%
68.6%
158.1%
Avg
597.7%
31.2%
119.1%
Low
488.0%
-22.7%
87.3%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.